Topical NSAID (post-operative)
Bromfenac
Brand names: Yellox
Adult dose
Dose: 1 drop BD starting day after surgery for 2 weeks
Route: Ophthalmic
Frequency: BD
Clinical pearls
- RCOphth: post-cataract inflammation/CMO prophylaxis
- Limit duration to 2 weeks unless specialist supervision
Contraindications
- Active corneal epithelial defect
- NSAID hypersensitivity
- Severe asthma triggered by aspirin
Side effects
- Stinging
- Corneal erosion
- Delayed corneal healing
- Allergic conjunctivitis
Interactions
- Concurrent topical steroids (delayed healing risk)
Monitoring
- Corneal integrity
- Symptoms
Reference: BNF; RCOphth; SmPC; https://bnf.nice.org.uk/drugs/bromfenac/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ASA Physical Status Classification · Pre-operative Risk
- Aldrete Score for Post-Anaesthesia Discharge · Post-operative
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- Apfel Score (Post-operative Nausea and Vomiting) · PONV
- Revised Cardiac Risk Index (RCRI) · Pre-operative Risk
- Duke Activity Status Index (DASI) · Functional Assessment
Pathways
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme